Literature DB >> 22075773

Knowledge of and attitudes toward nonpharmacological interventions for treatment of behavior symptoms associated with dementia: a comparison of physicians, psychologists, and nurse practitioners.

Jiska Cohen-Mansfield1, Barbara Jensen, Barbara Resnick, Margaret Norris.   

Abstract

PURPOSE OF THE STUDY: Behavior problems are common in nursing homes. Current guidelines recommend nonpharmacological interventions (NPHIs) as first-line treatment, but pharmacological regimens (PIs) continue to be used. Given differences in background and training of those who treat behavior problems in residents, we compared attitudes of physicians (MDs), psychologists (PhDs), and nurse practitioners (NPs) concerning PI and NPHI usage as well as knowledge of NPHIs. DESIGN AND METHODS: One hundred and eight MDs, 36 PhDs, and 89 NPs responded to a web-based questionnaire that captured level of agreement with statements concerning treatment of behavior symptoms and familiarity with NPHIs.
RESULTS: NPs were the most favorable toward NPHIs. MDs were significantly more favorable to the use of PIs than were PhDs, with attitudes of NPs falling in between. All felt that NPHI usage should increase and that NPHIs should be implemented before using PIs but also believed that PIs work well for behavior problems. MDs had significantly lower knowledge of NPHIs than PhDs or NPs. Overall, NPHI knowledge was similar for PhDs and NPs, although they differed on their use of specific interventions. IMPLICATIONS: As levels of knowledge and familiarity with NPHIs differed among providers, it is conceivable that all might benefit from training and experience with a wider range of NPHIs. Future studies might evaluate the impact of a uniform understanding of NPHI on communication and teamwork in nursing homes and examine ways to enhance a multidisciplinary approach that would allow for the tailoring and individualization that is required of successful interventions.

Entities:  

Mesh:

Year:  2011        PMID: 22075773     DOI: 10.1093/geront/gnr081

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  6 in total

1.  [Antipsychotics for treatment of neuropsychiatric disorders in dementia].

Authors:  H-J Gertz; G Stoppe; B Müller-Oerlinghausen; L G Schmidt; C Baethge; C Hiemke; K Lieb; T Bschor
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

2.  Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale.

Authors:  Ann Kolanowski; Richard H Fortinsky; Margaret Calkins; Davangere P Devanand; Elizabeth Gould; Tamar Heller; Nancy A Hodgson; Helen C Kales; Jeffrey Kaye; Constantine Lyketsos; Barbara Resnick; Melanie Schicker; Sheryl Zimmerman
Journal:  J Am Med Dir Assoc       Date:  2018-08-23       Impact factor: 4.669

3.  The Impact of Aliviado Dementia Care-Hospice Edition Training Program on Hospice Staff's Dementia Symptom Knowledge.

Authors:  Catherine E Schneider; Alycia Bristol; Ariel Ford; Shih-Yin Lin; Joyce Palmieri; Martina R Meier; Abraham A Brody
Journal:  J Pain Symptom Manage       Date:  2020-05-15       Impact factor: 3.612

Review 4.  Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy.

Authors:  E O Ijaopo
Journal:  Transl Psychiatry       Date:  2017-10-31       Impact factor: 6.222

5.  The recognition and management of neuropsychiatric symptoms in early Alzheimer's disease: a qualitative study among Dutch memory clinic physicians.

Authors:  Willem S Eikelboom; Najoua Lazaar; Rozemarijn L van Bruchem-Visser; Francesco U S Mattace-Raso; Michiel Coesmans; Rik Ossenkoppele; Esther van den Berg; Janne M Papma
Journal:  Psychogeriatrics       Date:  2022-07-10       Impact factor: 2.295

6.  Improving competencies in evidence-based dementia care: Results from a pilot study on a novel inter-professional training course (the KOMPIDEM project).

Authors:  Katrin Balzer; Rhian Schröder; Anne Junghans; Ute Stahl; Jens-Martin Träder; Sascha Köpke
Journal:  GMS J Med Educ       Date:  2016-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.